Sep 272017
 
Following discussion at the weekend (AOP Therapeutics) about 0.01% Atropine, there was some debate about off-label – use for other than the licensed indication e.g Doxy for blepharitis, and unlicensed medicines which IP optoms cannot access. The general consensus was that 0.01% Atropine would be off-label since Atropine itself is licensed, however that appears not [...]